当前位置: 首页 > 期刊 > 《中国医学创新》 > 2017年第25期
编号:13109170
长时程连续心电监控房颤对预防缺血性卒中后复发的临床研究(4)
http://www.100md.com 2017年9月5日 《中国医学创新》 2017年第25期
     [13] Bjorck S,Palaszewski B,Friberg L,et al.Atrial fibrillation, stroke risk, and warfarin therapy revisited:a population-based study[J].Stroke,2013,44(11):3103-3108.

    [14] Gattellari M,Goumas C,Aitken R,et al.Outcomes for patients withischaemic stroke and atrial fibrillation: the PRISM study (A Program ofResearch Informing Stroke Management)[J].Cerebrovasc Dis,2011,32(4):370-382.

    [15] Ogilvie I M,Newton N,Welner S A,et al.Underuse of oralanticoagulants in atrial fibrillation: a systematic review[J].Am J Med,2010,123(7):638-645.

    [16] Lip G Y.Stroke and bleeding risk assessment in atrial fibrillation:when, how, and why[J].European Heart J,2011,13(5):723.

    [17] Healey J S,Connolly S J,Gold M R,et al.ASSERT Investigators.Subclinical atrial fibrillation and the risk of stroke[J].N Engl J Med,2012,366:120-129.

    [18]南京,楊水详.阵发性心房纤颤与脑卒中研究进展[J].中华老年心血管病杂志,2015,17(6):665-667.

    [19] Weber-Krüger M,Gr?schel K,Mende M,Seegers J,et al. Excessive supraventricular ectopic activity is indicative of paroxysmal atrialfibrillation in patients with cerebral ischemia[J].PLoS One,2013,8(6):e67 602.

    [20] Sirimarco G,Hirt L,Sztajzel R,et al.Stroke prevention in patients with atrial fibrillation[J].Rev Med Suisse,2017,13(560):911-915.

    (收稿日期:2017-08-10) (本文编辑:周亚杰), 百拇医药(姚文艳 邵慧珺 刘媛)
上一页1 2 3 4